CPRT vs RGEN · P/E 19, rev $3.51B vs P/E 143, rev $204.1M
Copart Inc (CPRT) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the CPRT and RGEN stock pages for the full models.
Not investment advice.